The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Medi News


     

   Subscribe/Renew Journal


GlaxoSmithKline's (GSK) has received an important boost after two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 212

PDF Views: 0




  • Medi News

Abstract Views: 212  |  PDF Views: 0

Authors

Abstract


GlaxoSmithKline's (GSK) has received an important boost after two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS.